Business Description

HCA Healthcare Inc
NAICS : 622110
SIC : 8062
Compare
Compare
Traded in other countries / regions
H1CA34.Brazil2BH.GermanyHCA.Mexico0J1R.UKHCA.USA Description
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -0.05 | |||||
Debt-to-Equity | -14.4 | |||||
Debt-to-EBITDA | 3 | |||||
Interest Coverage | 5.19 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.73 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.5 | |||||
3-Year EBITDA Growth Rate | 17.6 | |||||
3-Year EPS without NRI Growth Rate | 23.9 | |||||
3-Year FCF Growth Rate | 12.3 | |||||
3-Year Book Growth Rate | -5.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.85 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.88 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.66 | |||||
9-Day RSI | 61.78 | |||||
14-Day RSI | 59.56 | |||||
6-1 Month Momentum % | 7.44 | |||||
12-1 Month Momentum % | 4.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 78.75 | |||||
Days Sales Outstanding | 51.73 | |||||
Days Payable | 157.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.89 | |||||
Dividend Payout Ratio | 0.12 | |||||
3-Year Dividend Growth Rate | 11.9 | |||||
Forward Dividend Yield % | 0.92 | |||||
5-Year Yield-on-Cost % | 0.89 | |||||
3-Year Average Share Buyback Ratio | 5.8 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.44 | |||||
Operating Margin % | 15.03 | |||||
Net Margin % | 9.37 | |||||
ROE % | Neg. Equity | |||||
ROA % | 10.92 | |||||
ROIC % | 17.45 | |||||
ROC (Joel Greenblatt) % | 34.14 | |||||
ROCE % | 24.61 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.6 | |||||
Forward PE Ratio | 15.17 | |||||
PE Ratio without NRI | 13.6 | |||||
Shiller PE Ratio | 23.44 | |||||
Price-to-Owner-Earnings | 15.58 | |||||
PEG Ratio | 0.87 | |||||
PS Ratio | 1.28 | |||||
Price-to-Free-Cash-Flow | 18.46 | |||||
Price-to-Operating-Cash-Flow | 8.97 | |||||
EV-to-EBIT | 10.93 | |||||
EV-to-Forward-EBIT | 12.49 | |||||
EV-to-EBITDA | 8.49 | |||||
EV-to-Forward-EBITDA | 9.32 | |||||
EV-to-Revenue | 1.87 | |||||
EV-to-Forward-Revenue | 1.81 | |||||
EV-to-FCF | 27.34 | |||||
Price-to-Projected-FCF | 1.29 | |||||
Price-to-DCF (Earnings Based) | 0.38 | |||||
Price-to-DCF (FCF Based) | 0.66 | |||||
Price-to-Median-PS-Value | 1.46 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.89 | |||||
Earnings Yield (Greenblatt) % | 9.15 | |||||
Forward Rate of Return (Yacktman) % | 20.36 |